|
Federal
Register Notices > Manufacturers
2009 > Aldrich Chemical Company Inc., DBA Isotec
FR Doc E9-25893[Federal Register: October 28, 2009 (Volume 74, Number 207)]
[Notices] [Page 55588] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr28oc09-112]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec.
1301.33(a) of Title 21 of the Code of Federal Regulations (CFR), this is
notice that on April 9, 2009, Aldrich Chemical Company Inc., DBA Isotec, 3858
Benner Road, Miamisburg, Ohio 45342-4304, made application by renewal to the
Drug Enforcement Administration (DEA) as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
| Drug |
Schedule |
| Gamma Hydroxybutyric Acid (2010) |
I |
| Methaqualone (2565) |
I |
| Ibogaine (7260) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| Psilocyn (7438) |
I |
| Normorphine (9313) |
I |
| Acetylmethadol (9601) |
I |
| Alphacetylmethadol except levo-alphacetylmethadol (9603) |
I |
| Normethadone (9635) |
I |
| Norpipanone (9636) |
I |
| 3-Methylfentanyl (9813) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Methylphenidate (1724) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| Phenylacetone (8501) |
II |
| 1-Piperidinocyclohexane-carbonitrile (8603) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Benzoylecgonine (9180) |
II |
| Ethylmorphine (9190) |
II |
| Hydrocodone (9193) |
II |
| Isomethadone (9226) |
II |
| Meperidine (9230) |
II |
| Meperidine intermediate-A (9232) |
II |
| Meperidine intermediate-B (9233) |
II |
| Methadone (9250) |
II |
| Methadone intermediate (9254) |
II |
| Dextropropoxyphene, bulk, (non-dosage forms) (9273) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Oxymorphone (9652) |
II |
The company plans to manufacture small quantities of the listed controlled
substances to produce isotope labeled standards for drug testing and analysis.
Any other such applicant, and any person who is presently registered with
DEA to manufacture such substances, may file comments or objections to the
issuance of the proposed registration pursuant to 21 CFR 1301.33(a).
Any such written comments or objections should be addressed, in
quintuplicate, to the Drug Enforcement Administration, Office of Diversion
Control, Federal Register Representative (ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be filed no later than December 28,
2009.
Dated: October 20, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-25893 Filed 10-27-09; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
